Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2001-11-29
2009-06-09
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S014800, C514S017400
Reexamination Certificate
active
07544653
ABSTRACT:
Repetitive and bioreactive regions of pro-opiliomelanocortin were identified using computational analysis. These regions KOMET, KOMET-1, KOMET-2, and KOMET-3 exhibit cytoprotective effects and may be administered to a patient to obtain better and stronger pharmacologic effects on the systemic and local modulation of inflammation and wound healing.
REFERENCES:
patent: WO 9909991 (1999-03-01), None
patent: WO 0004873 (2000-02-01), None
patent: WO 0069900 (2000-11-01), None
(P. Konjecvoda, et al. J. Phys. Paris (2001) 95, pp. 277-281.
P.W. Tinsley, et al. Peptides (1989) 9, pp. 1373-1379.
P. Konjevoda,, et al. Croatica Chemica Acta. (2000) 73(4), pp. 1111-1120.
Baranyi L.et al. (1995) “The antisense homology box: A new motif within proteins that encodes biologically active peptides.” Nature Medicine 1: 894-901.
Blalock J.E. (1995) “Genetic Origins of protein shapes and interactions rules” Nature Medicine, 1: 876-878.
Konjevoda P. et al. (2000) “Protective Effects of Met-enkephalin on Alcohol Induced Gastric Lesions” Croat. Chem. Acta 73: 1111-1121.
Lipton J.M. et al. (1997) “Anti-inflammatory actions of the neuroimmunomodulator α-MSH” ImonoI. Today 18 (1997) 140-145.
Plotnikoff et al. (1997) “Methionine Enkephalin: A new Cytokine—Human Studies” Clin. Immunol. Immunnopath. 82: 93-101.
{hacek over (S)}tambuk N et al. (1999) “Computational Determination of biologically active motifs of the bone morphogentic protein precursors” Period. Biol. 101: 363-368.
{hacek over (S)}tambuk N. (1998) “On the Optimization of Complementary Protein Coding” in: S. Ohno, K. Aoki, M. Usui, E. Uchio (Eds.), Uveitis Today, Elsevier, Amsterdam, pp. 315-318.
{hacek over (S)}tambuck, et al. (1998) “Simple Three-step Method for the Analysis and Design of Repetitive and Bioactive protein Motifs”, in: V. B. Bajić (Ed.), Advances in Systems Signals Control and Computers vol. II, IAAMSAD, and ANS, Durban, pp. 310-311.
{hacek over (S)}tambuk, N. et al. (1998) “Cytogenic effects on met-enkephalin (peptid-M) on human lymphocytes.” Croat. Chem. Acta 71 591-605.
Ademovic Zlatko
Konjevoda Pasko
Mikus Darko
Stambuk Nikola
Kosar Andrew D
Morgan & Lewis & Bockius, LLP
LandOfFree
Additive cytoprotective effects of two bioactive regions of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Additive cytoprotective effects of two bioactive regions of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Additive cytoprotective effects of two bioactive regions of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4100297